PDCD1LG2 and cancer: High levels of PD-L2 in cancer cells was further evaluated and found to be an independent prognostic factor in ER+ patients of the main cohort after adjustment for common clinicopathological variables and internal validation using bootstrap-based optimism correction (HR, 2.0; 95% CI, 1.4 to 2.9; P < .001; Table 2).